Impax Laboratories (IPXL) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Patent litigation: 3.28M
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
Patent litigation: 3.28M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q3 EPS of $0.23, $0.03 better than the analyst estimate of $0.20. Revenue for the quarter came in at $206.4 million versus the consensus estimate of $208.36 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- Prabhudas Lilladher Starts Aditya Birla Sun Life AMC (ABSLAMC:IN) at Buy (1)
- BRC Group Holdings to acquire Sangoma Technologies for ~$204M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
